TransMedics Group Overview
- Year Founded
-
1998
- Status
-
Public
- Employees
-
898
- Stock Symbol
-
TMDX
- Investments
-
4
- Share Price
-
$85.25
- (As of Friday Closing)
TransMedics Group General Information
Description
TransMedics Group Inc is a commercial-stage medical technology company transforming organ transplant therapy for end-stage organ failure patients across multiple disease states. It has developed the Organ Care System (OCS) to comprehensively address the limitations of cold storage. The OCS is a portable organ perfusion, optimization, and monitoring system that utilizes technology to replicate near-physiologic conditions for donor organs outside of the human body. The company has developed and is commercializing a proprietary system to preserve and deliver human organs for transplant in a near-physiologic condition to address the limitations of cold storage organ preservation.
Contact Information
Website
www.transmedics.comCorporate Office
- 200 Minuteman Road
- Suite 302
- Andover, MA 01810
- United States
Corporate Office
- 200 Minuteman Road
- Suite 302
- Andover, MA 01810
- United States
TransMedics Group Stock Performance
As of 20-Nov-2026, TransMedics Group’s stock price is $85.25. Its current market cap is $2.96B with 34.7M shares.
(As of Friday Closing)
| Stock Price | Previous Close | 52 wk Range | Market Cap | Shares | Average Volume | EPS |
|---|---|---|---|---|---|---|
| $85.25 | $94.02 | $60.10 - $156.00 | $2.96B | 34.7M | 926K | $4.21 |
TransMedics Group Financials Summary
As of 30-Sep-2026, TransMedics Group has a trailing 12-month revenue of $728M.
|
In Thousands, USD |
TTM 30-Sep-2026 | FY 2025 31-Dec-2025 | FY 2024 31-Dec-2024 | FY 2023 31-Dec-2023 |
|---|---|---|---|---|
| EV | 3,288,686 | 4,210,482 | 2,280,613 | 2,665,424 |
| Revenue | 727,650 | 605,494 | 441,540 | 241,623 |
| EBITDA | 139,057 | 148,504 | 69,989 | (7,680) |
| Net Income | 144,453 | 190,291 | 35,464 | (25,028) |
| Total Assets | 1,517,937 | 1,068,373 | 804,076 | 706,047 |
| Total Debt | 866,902 | 519,278 | 518,287 | 515,946 |
TransMedics Group Valuation & Funding
| Deal Type | Date | Amount | Valuation/ EBITDA |
Post-Val | Status | Debt |
|---|
TransMedics Group Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|
TransMedics Group Comparisons
Industry
Financing
Details
TransMedics Group Competitors (24)
One of TransMedics Group’s 24 competitors is Angiodynamics, a Corporation company based in Latham, NY.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Angiodynamics | Corporation | Latham, NY | ||||
| OrganOx | Formerly PE-Backed | Oxford, United Kingdom | ||||
| Organ Recovery Systems | Formerly VC-backed | Chicago, IL | ||||
| Abiomed | Corporate Backed or Acquired | Danvers, MA | ||||
| Lifetech Scientific | Formerly VC-backed | Shenzhen, China |
TransMedics Group Patents
TransMedics Group Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| US-20260334461-A1 | Apparatus and system for perfusing an ex-vivo lung without a gas exchange device | Pending | 25-Apr-2025 | ||
| WO-2026226699-A1 | Apparatus and system for perfusing an ex-vivo lung without a gas exchange device | Pending | 25-Apr-2025 | ||
| US-20260334462-A1 | Apparatuses for supporting an ex-vivo organ | Pending | 25-Apr-2025 | ||
| WO-2026226716-A1 | Apparatuses for supporting an ex-vivo organ | Pending | 25-Apr-2025 | ||
| US-20260344659-A1 | Compositions, methods, and devices for using ketone to preserve ex-vivo hearts | Pending | 25-Apr-2025 | A01N1/143 |
TransMedics Group Signals
TransMedics Group Investments & Acquisitions (4)
TransMedics Group’s most recent deal was a Merger/Acquisition with PAD Aviation Service. The deal was made on 06-Jul-2026.
| Company Name | Deal Date | Deal Type | Deal Size | Industry | Lead Partner |
|---|---|---|---|---|---|
| PAD Aviation Service | 06-Jul-2026 | Merger/Acquisition | Air | ||
| Summit Aviation (Air) | 16-Aug-2023 | Merger/Acquisition | Air | ||
| Bridge to Life (Warm Perfusion EVOSS and Cold Perfusion LifeCradle Technologies) | 02-Aug-2023 | Corporate Asset Purchase | Other Healthcare Technology Systems | ||
| Swissmed | 01-Jan-2022 | Merger/Acquisition | Distributors (Healthcare) |
TransMedics Group ESG
Risk Overview
Risk Rating
Updated November, 04, 2026
27 | Med Risk
Risk Scale
A lower score indicates better sustainability
Negl
0-10
Low
10-20
Med
20-30
High
30-40
Severe
40+
Exposure
Exposure refers to the extent to which a company is exposed to different material ESG issues
Management
Management is related to actions taken to manage ESG issues
Peers Analysis
Peer performance insights compare the company’s ESG performance to the performance of selected peers to help inform future ESG decisions and drive internal performance improvements.
Global
Covered Companies
of 13,593
Rank
Percentile
Healthcare
Industry
of 590
Rank
Percentile
Medical Devices
Subindustry
of 209
Rank
Percentile
TransMedics Group Affiliates
Subsidiaries (4)
| Name | Industry | Location | Year Founded |
|---|---|---|---|
| Northside Property Group | Bozeman, MT | 2023 | |
| PAD Aviation Service | Buren, Germany | 1996 | |
| Tmdx, Inc.2 | Andover, MA | ||
| Transmedics, Inc.1 | Andover, MA |
TransMedics Group FAQs
-
When was TransMedics Group founded?
TransMedics Group was founded in 1998.
-
Where is TransMedics Group headquartered?
TransMedics Group is headquartered in Andover, MA.
-
What is the size of TransMedics Group?
TransMedics Group has 898 total employees.
-
What industry is TransMedics Group in?
TransMedics Group’s primary industry is Other Devices and Supplies.
-
Is TransMedics Group a private or public company?
TransMedics Group is a Public company.
-
What is TransMedics Group’s stock symbol?
The ticker symbol for TransMedics Group is TMDX.
-
What is the current stock price of TransMedics Group?
As of 20-Nov-2026 the stock price of TransMedics Group is $85.25.
-
What is the current market cap of TransMedics Group?
The current market capitalization of TransMedics Group is $2.96B.
-
What is TransMedics Group’s current revenue?
The trailing twelve month revenue for TransMedics Group is $728M.
-
Who are TransMedics Group’s competitors?
Angiodynamics, OrganOx, Organ Recovery Systems, Abiomed, and Lifetech Scientific are some of the 24 competitors of TransMedics Group.
-
What is TransMedics Group’s annual earnings per share (EPS)?
TransMedics Group’s EPS for 12 months was $4.21.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process